Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Saunders-Pullman

Showing results (71-80 of 133) with videos related to

Pageof 14
Sort By:
Neurobiology of Disease|August 20, 2019
Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competitionElena Arystarkhova, Ihtsham U Haq, Timothy Luebbert, et al.
Frontiers in Neurology|March 15, 2021
Cognitive Functioning of Glucocerebrosidase (<i>GBA</i>) Non-manifesting CarriersEileen E Moran, Susan B Bressman, Roberto A Ortega, et al.
Neurology|June 12, 2015
Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 ConsortiumKaren Marder, Yuanjia Wang, Roy N Alcalay, et al.
Annals of Clinical and Translational Neurology|December 11, 2014
Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?Rachel Saunders-Pullman, Anat Mirelman, Cuiling Wang, et al.
The New England Journal of Medicine|January 27, 2006
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi JewsLaurie J Ozelius, Geetha Senthil, Rachel Saunders-Pullman, et al.
JAMA Neurology|November 18, 2014
Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysisIlir Agalliu, Marta San Luciano, Anat Mirelman, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 10, 2016
Glucocerebrosidase enzyme activity in GBA mutation Parkinson's diseaseRoberto A Ortega, Paola A Torres, Matthew Swan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 20, 2015
Low-variance RNAs identify Parkinson's disease molecular signature in bloodMaria D Chikina, Christophe P Gerald, Xianting Li, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 20, 2016
Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's diseaseConnie Marras, Roy N Alcalay, Chelsea Caspell-Garcia, et al.
Journal of Genetic Counseling|August 17, 2014
Interest in genetic testing in Ashkenazi Jewish Parkinson's disease patients and their unaffected relativesManisha Gupte, Roy N Alcalay, Helen Mejia-Santana, et al.
Pageof 14

Showing results (71-80 of 133) with videos related to

Sort By:
Pageof 14
Neurobiology of Disease|August 20, 2019
Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competitionElena Arystarkhova, Ihtsham U Haq, Timothy Luebbert, et al.
Frontiers in Neurology|March 15, 2021
Cognitive Functioning of Glucocerebrosidase (<i>GBA</i>) Non-manifesting CarriersEileen E Moran, Susan B Bressman, Roberto A Ortega, et al.
Neurology|June 12, 2015
Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 ConsortiumKaren Marder, Yuanjia Wang, Roy N Alcalay, et al.
Annals of Clinical and Translational Neurology|December 11, 2014
Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?Rachel Saunders-Pullman, Anat Mirelman, Cuiling Wang, et al.
The New England Journal of Medicine|January 27, 2006
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi JewsLaurie J Ozelius, Geetha Senthil, Rachel Saunders-Pullman, et al.
JAMA Neurology|November 18, 2014
Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysisIlir Agalliu, Marta San Luciano, Anat Mirelman, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 10, 2016
Glucocerebrosidase enzyme activity in GBA mutation Parkinson's diseaseRoberto A Ortega, Paola A Torres, Matthew Swan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 20, 2015
Low-variance RNAs identify Parkinson's disease molecular signature in bloodMaria D Chikina, Christophe P Gerald, Xianting Li, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 20, 2016
Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's diseaseConnie Marras, Roy N Alcalay, Chelsea Caspell-Garcia, et al.
Journal of Genetic Counseling|August 17, 2014
Interest in genetic testing in Ashkenazi Jewish Parkinson's disease patients and their unaffected relativesManisha Gupte, Roy N Alcalay, Helen Mejia-Santana, et al.
Pageof 14